Grants for Public and State controlled institutions of higher education - Health

This grant provides funding for nonprofit organizations and higher education institutions to create hands-on research projects that engage public health students in studying and addressing drug control policies and trends.

This funding opportunity supports researchers in discovering and validating new targets for developing safe and effective pain treatments with minimal side effects and low addiction risk.

iHIT – Ideas – High-return, Innovative, Transformative o Supports ideas in bioscience research that are in the development stage and promise to have a high economic return for innovative and transformative research projects. o This mechanism intends to support applicants to develop novel lines of multidisciplinary research different from their ongoing research. o Up to $75,000 for 1 year.Proposal must be submitted as a single electronic PDF document at the link provided on the CAT website https://cat.dbi.udel.edu. Please note that submission and award processes have changed.

This funding opportunity provides financial support to rural healthcare organizations in the Delta region to improve service delivery, enhance sustainability, and expand access to care through specific projects.

This funding initiative provides financial support to Virginia law enforcement agencies and educational institutions to establish and maintain co-responder teams that collaborate with mental health professionals in crisis situations.

Cox Communications, in partnership with the Arizona Community Foundation, offers grants through Cox Charities to support nonprofit organizations in Arizona. This program aligns with the foundation's mission to enhance communities by investing in key areas. Eligible organizations include Arizona 501(c)(3) entities, government agencies, and tribal entities, with religious organizations able to apply for non-sectarian programs. The program aims to foster positive community impact by supporting initiatives that address critical social needs within the state. The Cox Charities grant program targets beneficiaries across several key focus areas: Education, with a priority on K-12 and STEAM initiatives; Diversity, specifically programs serving 80% or more of a target population or promoting inclusion, diversity, and equity; Environment/Sustainability, focusing on water conservation, waste reduction, or carbon reduction; and Digital Equity, supporting digital literacy programs, computer distribution, or services for underserved communities. These priorities reflect the foundation's strategic focus on empowering individuals and communities through access to essential resources and opportunities. The expected outcomes of the Cox Charities grant program are centered on measurable results within these focus areas. For education, the goal is to improve educational attainment and skills, particularly in STEM fields. Diversity initiatives aim to foster more inclusive communities and reduce disparities. Environmental grants seek tangible improvements in sustainability practices, such as reduced water consumption or waste. Digital equity programs are expected to increase digital literacy and access, bridging the digital divide for underserved populations. The grant duration is not specified, but grants typically range from $2,500 to $10,000. The foundation's strategic priorities and theory of change are evident in its commitment to supporting programs that directly address identified community needs and create lasting impact. By prioritizing specific areas like K-12 and STEAM education, targeted diversity programs, environmental sustainability, and digital literacy, Cox Charities aims to drive systemic change. They emphasize fiscal accountability and responsibility among applicants, and organizations must demonstrate a non-discrimination policy. Furthermore, providing opportunities for Cox Communications Arizona employees to volunteer or serve on boards highlights a belief in community engagement and shared responsibility for achieving these outcomes.

The National Human Genome Research Institute (NHGR) intends to promote a new initiative by publishing a Notice of Funding Opportunity (NOFO) to advance scholarship on the ethical, legal, and social implications (ELSI) of advances in human genetics or genomics, enhance ELSI research teams, build ELSI research capacity, and broaden the ELSI workforce.The intended NOFO will be based on aconceptrecently approved by the National Advisory Council on Human Genome Research and accompanyingdiscussion. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects, and to consult with NIH following release of the intended NOFO to submit responsive applications. The NOFO is expected to be published in summer of 2004 with an expected application due date in fall of 2024. This NOFO will utilize the UM1 activity code (Research Project with Complex Structure, Cooperative Agreement, Clinical Trial Optional). Details of the planned NOFO are provided below.

This Funding Opportunity Announcement (FOA) will support extramural research to investigate and mitigate challenges facing clinical assay development and subsequent analytical validation due to preanalytical variability in tumor tissue biopsies, blood biospecimens utilized as liquid biopsies", or other biospecimens as described in this FOA. Extramural research funded under this FOA may include investigations of preanalytical variability associated with the procurement and study of small biopsies (core biopsies, small excision samples), blood utilized for "liquid biopsies", tissue swabs, tissue secretions, pleural and esophageal aspirates, feces, or bodily fluids like sweat, urine, CSF, breast milk and saliva. Investigator-designed experiments will explore how different biospecimen preanalytical conditions affect emerging and clinically relevant biomarkers quantified by a variety of testing platforms. The results from this research program will improve the understanding of how analytical quantification of clinically relevant biomarkers is affected by variation in biospecimen collection, processing, and storage procedures. The overall goal is to expedite biomarker clinical assay development through evidence-based standardization of biopsy handling practices.

The "Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer" grant aims to fund preliminary research into how the human microbiome affects the body's immune response to cancer, with a focus on how specific microbes or their byproducts can either increase or prevent tumor formation, and how the amount, timing, and duration of beneficial microbes can impact their effectiveness.

This funding opportunity supports the development of a national data resource center to improve research on childhood cancers and congenital anomalies, encouraging collaboration among a wide range of organizations and researchers.

This funding opportunity provides financial support for educational programs that train new researchers in Down syndrome to improve understanding and treatment of co-occurring health conditions throughout the lifespan.

This grant provides funding for researchers at U.S. institutions to explore innovative uses of nanotechnology in cancer research, focusing on improving targeted delivery and diagnostic capabilities for specific cancer types.

The purpose of this Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions is to support small scale research grants at institutions that do not receive substantial funding from the NIH, with an emphasis on providing biomedical research experiences primarily for undergraduate students, and enhancing the research environment at these applicant institutions. Eligible institutions must award baccalaureate science degrees, and have received less than 6 million dollars per year of NIH support (total costs) in 4 of the last 7 fiscal years.

This funding opportunity supports research institutions and organizations in developing and testing new treatments and recovery methods for individuals with alcohol use disorder, particularly focusing on underserved populations and innovative approaches.

The "Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research" grant aims to encourage current NCI R01 research projects to incorporate new technologies from the NCI Innovative Molecular Analysis Technologies program, with the goal of enhancing their original research and speeding up scientific discoveries in cancer research.

This funding opportunity provides financial support to organizations working in Zambia to improve HIV and TB prevention, care, and treatment services through innovative and sustainable quality improvement strategies.

This funding opportunity supports U.S.-based organizations in developing a centralized hub to advance the use of artificial intelligence and technology in research related to aging and Alzheimer's Disease, fostering collaboration and stakeholder engagement across multiple projects.

The overall goal of this UG3/UH3 Exploratory/Developmental phased initiative is to support the discovery and development of novel natural products that are safe, nontoxic, and efficacious for cancer interception and prevention. 1. Purpose of UG3: Select clinically relevant targets and develop and validate assays for bioactivity as well as toxicity screening 2. Purpose of UH3 phase: Screening libraries, structure elucidation, full-scale characterization, efficacy testing, and development of the screened agents.

The Rural Business-Cooperative Service announces the availability of $3,000,000 in competitive grant funds for the FY 2024 Delta Health Care Services Grant (DHCS) Program as authorized under Section 379G of the Consolidated Farm and Rural Development Act (7 U.S.C. 2008u), as amended by the Agricultural Act of 2018 (Pub. L. 115-334). The purpose of this program is to provide financial assistance to address the continued unmet health needs in the Delta Region, through cooperation among health care professionals, institutions of higher education, research institutions and economic development entities in the Delta Region.

This grant provides access to specialized resources and expertise for researchers developing gene-based therapies for extremely rare neurological disorders, helping them prepare for regulatory submissions and advance their therapeutic projects.